Altman Peter Insider Trades & Stock Holdings

President and CEO · BioCardia, Inc. · Latest filing Sep 29, 2026

Altman Peter, President and CEO at BioCardia, Inc. has 2 Form 4 trades on file since Sep 23, 2026. Open-market activity: 2 purchases ($3.02K) and 0 sales ($0), net +$3.02K. Latest filing: acquired 1K shares of $BCDA on Sep 29, 2026 at $1.03.

Trades on file

2

Open-market bought

$3.02K

Open-market sold

$0

Net open-market

+$3.02K

Latest filing

Sep 29, 2026

All insider trades by Altman Peter

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Sep 29, 2026	$BCDA	Buy (Open-market buy)	1K	$1.03	$1.03K			+2.9%			President and CEO		—
Sep 23, 2026	$BCDA	Buy (Open-market buy)	1.90K	$1.05	$2K			-3.8%			President and CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Altman Peter traded

• $BCDA

Frequently asked questions

Has Altman Peter been buying or selling stock?

Altman Peter has 2 open-market purchases and 0 open-market sales on file, net +$3.02K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Altman Peter's latest insider trade?

acquired 1K shares of $BCDA on Sep 29, 2026 at $1.03.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.